Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 07, 2021
Avacta Group has entered into a license agreement with POINT to provide access to Avacta’s pre|CISION technology for the development of tumor-activated radiopharmaceuticals.
read more
Thursday, January 07, 2021
Ascentage announced its licensee, UNITY Biotechnology, has dosed the first patient in a Phase I clinical study of drug candidate UBX1325 in patients with diabetic macular edema.
read more
Thursday, January 07, 2021
Caprion-HistoGeneX announced the acquisition of CLI, a Virtual Central Specimen Management CRO based in Halifax, Canada.
read more
Wednesday, January 06, 2021
Panthera’s clinical trial sites began dosing volunteers in the Phase III trial which will evaluate AstraZeneca’s long-acting antibody combination for the potential prevention of COVID-19.
read more
Wednesday, January 06, 2021
Quartesian has earned ISO 9001:2015 certification for its quality management system and the ISO/IEC 27001:2013 certification for its systems and processes for managing sensitive company information.
read more
Wednesday, January 06, 2021
Servier and X-Chem announced a partnership to identify and develop novel small molecules for the treatment of neurological disorders.
read more
Wednesday, January 06, 2021
Silo Pharma has entered into an agreement to license technology covered by provisional patent applications filed by Silo Pharma.
read more
Wednesday, January 06, 2021
Oncorus has signed a 15-year lease to build an 88,000 square foot GMP viral immunotherapy clinical manufacturing facility in Andover, Massachusetts.
read more
Wednesday, January 06, 2021
Aurobindo Pharma and COVAXX have entered into an agreement to develop, commercialize and manufacture UB-612, the first Multitope Peptide-based Vaccine to fight COVID-19, for India and UNICEF.
read more
Tuesday, January 05, 2021
Slayback Pharma has received final approval for its ANDA for Merzee 1 mg/20 mcg from the FDA with a Competitive Generic Therapy Designation.
read more
Tuesday, January 05, 2021
Stäubli has announced a new Chief Executive Officer.
read more
Tuesday, January 05, 2021
Syneos Health announced the acquisition of Illingworth Research Group™, a provider of clinical research home health services.
read more
Tuesday, January 05, 2021
miRagen has gained exclusive rights to develop and commercialize therapeutic antibodies targeting IGF-1R incorporating Xtend Fc technology from Xencor.
read more
GT Biopharma and CDMO Cytovance have reached an agreement for license rights to use certain bacterial and mammalian cell lines and for GMP manufacturing services performed to date regarding the Company's TriKE™ product candidates.
read more
Teknova has completed the process of FDA notification for its Active Viral Transport Medium (ATM).
read more